![Ann Thorell](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ann Thorell
Directeur Financier/CFO chez
SERES THERAPEUTICS, INC.
Fortune : - $ au 31/05/2026
Profil
Ann Marella Thorell is currently Director at Living Beyond Breast Cancer, Director at ApcinteX Ltd. since 2021, and Chief Financial Officer & Executive Vice President at Seres Therapeutics, Inc. starting in 2024.
Former roles include Chairman at Vallon Pharmaceuticals, Inc. from 2022 to 2023; COO, CFO, Secretary & Executive Director at Realm Therapeutics Plc from 2014 to 2019; Director at Capella Bioscience Ltd. and Z Factor Ltd. from 2021 to 2022; Independent Director at ESSA Pharma, Inc. from 2019 to 2025 and at Carisma Therapeutics, Inc. from 2024 to 2025; CFO, Treasurer, SVP & Chief Accounting Officer at Evelo Biosciences, Inc. in 2023; President at Thorell Consulting; Chief Financial Officer at Palladio Biosciences, Inc. from 2019 to 2021; and Chief Accounting Officer at Centessa Pharmaceuticals Plc from 2021 to 2022.
Education includes undergraduate studies at Lehigh University.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 13/04/2026 | 0 ( -.--% ) | - $ | 31/05/2026 | |
| 31/05/2025 | 0 ( -.--% ) | - $ | 31/05/2026 |
Postes actifs de Ann Thorell
| Sociétés | Poste | Début |
|---|---|---|
| SERES THERAPEUTICS, INC. | Directeur Financier/CFO | 25/03/2024 |
ApcinteX Ltd.
 ApcinteX Ltd. BiotechnologyHealth Technology Manufactures novel hemophilia drugs | Directeur/Membre du Conseil | 29/01/2021 |
Living Beyond Breast Cancer
 Living Beyond Breast Cancer Living Beyond Breast Cancer is a company based in Haverford, PA. Jean A. Sachs has been the CEO of the company since 1996. | Directeur/Membre du Conseil | - |
Anciens postes connus de Ann Thorell
| Sociétés | Poste | Fin |
|---|---|---|
| CARISMA THERAPEUTICS, INC. | Directeur/Membre du Conseil | 31/12/2025 |
| ESSA PHARMA INC. | Directeur/Membre du Conseil | 09/10/2025 |
| EVELO BIOSCIENCES, INC. | Directeur Financier/CFO | 20/11/2023 |
| GRI BIOPAR | Président | 21/04/2023 |
| CENTESSA PHARMACEUTICALS PLC | Comptroller/Controller/Auditor | 31/07/2022 |
Formation de Ann Thorell
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
45
Relations au 1er degré
14
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 14 |
|---|---|
Realm Therapeutics Plc
 Realm Therapeutics Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical stage biopharmaceutical company that develops proprietary immunomodulatory products | Health Technology |
Lehigh University
 Lehigh University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Living Beyond Breast Cancer
Living Beyond Breast Cancer Living Beyond Breast Cancer is a company based in Haverford, PA. Jean A. Sachs has been the CEO of the company since 1996. | |
ESSA Pharma, Inc.
 ESSA Pharma, Inc. Pharmaceuticals: MajorHealth Technology Develops small molecule drugs | Health Technology |
Seres Therapeutics, Inc.
 Seres Therapeutics, Inc. BiotechnologyHealth Technology Develops novel treatments for diseases related to the human microbiome | Health Technology |
Evelo Biosciences, Inc.
 Evelo Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops oral therapeutics for small intestine related diseases | Health Technology |
Capella Bioscience Ltd.
 Capella Bioscience Ltd. Pharmaceuticals: MajorHealth Technology Develops novel medicines based on monoclonal antibodies to the next generation therapeutic targets in oncology and autoimmune disease | Health Technology |
Z Factor Ltd.
 Z Factor Ltd. BiotechnologyHealth Technology Engages in research and development of therapeutic agents to treat alpha-1 antitrypsin deficiency | Health Technology |
ApcinteX Ltd.
ApcinteX Ltd. BiotechnologyHealth Technology Manufactures novel hemophilia drugs | Health Technology |
Thorell Consulting
 Thorell Consulting Miscellaneous Commercial ServicesCommercial Services Provides business consulting services | Commercial Services |
Palladio Biosciences, Inc.
 Palladio Biosciences, Inc. BiotechnologyHealth Technology Develops transformative medicines for orphan diseases | Health Technology |
Vallon Pharmaceuticals, Inc.
 Vallon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which develops and commercializes proprietary biopharmaceutical products | Health Technology |
Centessa Pharmaceuticals Plc
 Centessa Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company that researches and develops medicines for neurological, neurodegenerative and neuropsychiatric disorders | Health Technology |
Carisma Therapeutics, Inc.
 Carisma Therapeutics, Inc. BiotechnologyHealth Technology Develops novel chimeric antigen receptor macrophage and CAR-monocyte technology treatment of non-muscle invasive bladder cancer | Health Technology |
